Oral anticoagulation may prolong survival of a subgroup of patients with cancer: A cochrane systematic review

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 2, 2007, Pages 175-184

  Akl, Elie A ^a   Kamath, G ^a   Kim, S Y ^a   Yosuico, V ^a   Barba, M ^b   Terrenato, I ^b   Sperati, F ^b   Schunemann H J ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cancer; Coumadin; Oral anticoagulant; Vitamin K antagonist; Warfarin; Ximelagatran

Indexed keywords

4 HYDROXYCOUMARIN; ANTIVITAMIN K; ARDEPARIN; CERTOPARIN; COUMARIN; DALTEPARIN; DANAPAROID; ENOXAPARIN; FONDAPARINUX; HEPARIN; NADROPARIN; PLACEBO; REVIPARIN; TINZAPARIN; WARFARIN; XIMELAGATRAN;

BLEEDING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTICOAGULANTS; CARCINOMA, SMALL CELL; HUMANS; LUNG NEOPLASMS; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; WARFARIN;

EID: 34347406492     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Dvorak H.F.: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. New England Journal of Medicine 25; 315(26):1650-9, 1986.
2. Francis J.L., Biggerstaff J., Amirkhosravi A.: Hemostasis and malignancy. Seminars in Thrombosis & Hemostasis;24(2):93-109, 1998.
3. Levine M.N., Lee A.Y., Kakkar A.K.: From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer. Journal of Thrombosis & Haemostasis 1; 1(7): 1456-63, 2003.
4. Miller G.J., Bauer K.A., Howarth D.J., Cooper J.A., Humphries SE, Rosenberg RD. Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway. Journal of Thrombosis & Haemostasis 2(12):2107-14, 2004.
5. Smorenburg S.M., Van Noorden C.J.: The complex effects of heparins on cancer progression and metastasis in experimental studies. Pharmacological Reviews 53(1):93-105, 2001.
6. Schulman S., Lindmarker P.: Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. New England Journal of Medicine 29;342(26): 1953-1958, 2000.
7. Zacharski L.R., Henderson W.G., Rickles F.R. et al.: Effect of warfarin on survival in small cell carcinoma of the lung. Veterans administration study No. 75. Journal of the American Medical Association 245(8):831-835, 2001.
8. Maurer L.H., Herndon I.J., Hollis D.R., Aisner J., Carey R.W., Skarin A.T. et al.: Randomized trial of chemotherapy and radiation therapy with or without Warfarin for limited-stage small-cell lung cancer: A cancer and leukemia group B study. Journal of Clinical Oncology 15(11):3378-87, 1997.
9. Smorenburg S.M., Vink R., Otten H.M., Swaneveld F., Buller H.R.: The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis. Thrombosis & Haemostasis 86(6): 1586-7, 2001.
10. Chahinian A.P., Propert K.J., Ware J.H., Zimmer B., Perry M.C., Hirsh V., et al.: A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. Journal of Clinical Oncology 7(8):993-1002, 1989.
11. Daly L.: The first international urokinase/warfarin trial in colorectal cancer. Clinical & Experimental Metastasis 9(1):3-11, 1991.
12. Levine M., Hirsh J., Gent M., Arnold A., Warr D., Falanga A. et al.: Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 9;343(8902):886-889, 1994 .
13. Zacharski L.R., Henderson W.G., Rickles F.R., Forman W.B., Cornell C.J. Jr., Forcier R.J., et al.: Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Cancer 15;53(10):2046-2052, 1984.
14. Haynes R.B., Devereaux P.J., Guyatt G.H.: Clinical Expertise in the era of evidence based medicine and patient choice. ACP Journal Club, 136:A 11, 2002.